15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 6 firms covering Artivion Inc, 6 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a strong buy consensus. Targets are tightly clustered, $36.00 to $48.00, so the covering firms are broadly aligned. The average target of $42.67 sits 58% above the current $27.03. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.10 next quarter toward $0.72 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS6 ratings
Strong Buy
Strong Buy00%
Buy6100%
Hold00%
Sell00%
Strong Sell00%
Based on 6 analysts giving stock ratings to Artivion Inc.
As of Jul, 6 of 6 firms rate AORT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AORT EPS & revenue forecast
EPS · NEXT QUARTER
$0.10
Range $0.08 – $0.13 · 6 analysts · -36% YoY
Next period, 6 analysts expect Artivion Inc to earn $0.10 a share (range $0.08 – $0.13), versus $0.16 a year earlier. Full-year consensus is $0.44, growing to $0.72 the year after.
REVENUE · NEXT QUARTER
$121.5M
Range $118.8M – $124.8M · 6 analysts · +7% YoY
Revenue is expected to reach $121.5M (range $118.8M – $124.8M), +7.1% year-over-year. Full-year consensus is $486.2M, rising to $539.8M next year.
Top analysts covering Artivion Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AORT.
#1
William Plovanic
Canaccord Genuity · Rank #190
Buy
$36.00+33.2% to target
Overall win rate
36%
+ Follow
#2
Mike Matson
Needham · Rank #204
Buy
$44.00+62.8% to target
Overall win rate
31%
+ Follow
#3
Frank Takkinen
Lake Street · Rank #327
Buy
$45.00+66.5% to target
Overall win rate
26%
+ Follow
#4
MM
Michael Matson
Needham
Buy
$44.00+62.8% to target
Coverage
—
+ Follow
#5
DS
Daniel Stauder
Citizens
Buy
$48.00+77.6% to target
Coverage
—
+ Follow
AORT stock forecast FAQ
What is AORT's average 12-month price target?+
The 3 analysts with a live target average $42.67 for Artivion Inc over the next 12 months, ranging from a $48.00 high to a $36.00 low.
Is AORT stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 6 analyst ratings, 6 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AORT?+
The Street-high target is $48.00 (Citizens), and the Street-low is $36.00 (Canaccord Genuity). The average of all 3 active targets is $42.67.
How many Wall Street analysts cover AORT?+
6 analysts have an active rating on Artivion Inc, and 3 firms carry a live 12-month price target.
Who is the most accurate analyst covering AORT?+
Among analysts who currently cover AORT, William Plovanic of Canaccord Genuity has the strongest overall Quantellect track record (Rank #190). Their current call is Buy with a $36.00 target.
What is Artivion Inc's projected EPS for next quarter?+
The consensus estimate is $0.10 per share (range $0.08 – $0.13) across 6 analysts. Full-year EPS is projected at $0.44, rising to $0.72 the following year.
How much revenue is Artivion Inc expected to report next quarter?+
Consensus revenue is $121.5M (range $118.8M – $124.8M). Full-year revenue is projected at $486.2M, growing to $539.8M next year.
Have analysts been upgrading or downgrading AORT lately?+
As of Jul, 6 of 6 firms rate AORT a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AORT calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
